SCbio Demo Day Puts Startup Innovation, Capital Access in the Spotlight

Drive graduates pitch investor-ready science as part of a national life sciences accelerator collaboration between SCbio and Massbio

CHARLESTON, SC – May 14, 2026 – SCbio, in collaboration with MassBio, hosted life sciences investors and industry experts for Demo Day on Wednesday to showcase the science of 15 emerging companies and conclude the spring cohort of its national accelerator program, Drive.

After completing the 8-week hybrid program filled with industry-specific curriculum modules led by experts, this cohort of biomarkers and diagnostics companies took the stage to pitch their innovative science to gain the visibility, traction and potential funding needed to propel their startups forward.

The program included a panel discussion featuring Holly Soares, global head of neuroscience and rare disease biomarkers, vice president at Roche, and Matt Clancey, director of new ventures and strategic alliances at Labcorp, focused on practical guidance for early-stage companies positioning themselves for investment and strategic partnerships.

“These biomarkers and diagnostics companies are developing tools to redefine earlier cancer detection, treatment decisions for patients and other vital technologies that can be nurtured by South Carolina’s life sciences resources,” said James Chappell, Ph.D., president and chief executive officer of SCbio. “We want this cohort, and future cohorts, to witness the strength of our biomedical research community, the availability of incubator and lab space, and a culture that values collaboration between startups, universities, and industry.”

This year, SCbio honored two participating companies with Awards of Excellence in recognition of their outstanding pitch presentation and exceptional performance during the accelerator program.

Dxcover received a company presentation session at the 2026 Biocentury Grand Rounds conference, an event that gathers a global network of over 500 decision-makers to learn about business and biopharma research and development opportunities.

General Prognostics received a position as a South Carolina delegate at the 2026 BIO International Convention, the world’s largest industry gathering, bringing together thousands of global biotechnology and biopharmaceutical leaders, where they will make meaningful connections.

The Drive accelerator program selects up to six startups to participate in curriculum modules taught by industry experts at no cost to them. SCbio’s biomarkers and diagnostics cohort curriculum partners include Labcorp, Lilly, K&L Gates, Maynard Nexsen, The Matchstick Group, and VentureSouth, and is supported by premier sponsors Charleston County Economic Development and the South Carolina Department of Commerce.

Since launching in 2022, Drive has supported 59 early-stage companies (70 inclusive of the current cohort) that have raised $290 million in funding.

Applications for the Fall 2026 cohort of Drive will open May 26, 2026.

About SCbio

SCbio is the definitive, unifying leader in South Carolina’s life sciences sector, fostering authentic collaboration and innovation across academia, startups, government and established enterprises. As a member-driven economic development organization, SCbio represents an industry that generates $20.1 billion in annual economic impact and supports 63,000 jobs across South Carolina. Our members are unified by a mission to positively impact humanity through science across the ecosystem of advanced and specialty manufacturing; digital health and the data frontier; and cutting-edge health specializations. For additional information about SCbio and the life sciences industry, or to become a member, visit SCbio.org.

Media Contacts

Connor Watkins

Director of Marketing – SCbio
Cwatkins@scbio.org

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.